“On the US tax changes and all, the only thing which should bother Indians is the remittance tax which has been proposed, which could hurt the flow of remittances to some extent and increase the cost for the Indian diaspora staying in US, so that is something which will be a small concern, ex of … Read more
India Inc’s Q4 FY25 earnings season continues this week, with 81 companies scheduled to release their financial results. Key names to watch include ITC, Sun Pharma, IndusInd Bank, Power Grid Corporation of India, Hindalco, Interglobe Aviation (IndiGo), ONGC, Bharat Electronics, DLF, Dixon Technologies, Solar Industries, United Spirits, Ashok Leyland, Grasim, RVNL, and Honasa Consumer. Here … Read more
Shares of pharmaceutical companies rallied up to 4% on Tuesday as investors expect that US President Donald Trump‘s executive order will have minimal impact on US generics. Dr Reddy’s shares were up around 4% while Granules, Glenmark, Lupin, Divi’s Lab, and Aurobindo Pharma were trading around 3% higher. Nifty Pharma index itself rose around 2% … Read more
“Overall, what we need to understand is that markets have rallied significantly from the recent lows of 22,000 to currently trade around 24,300 plus. So, clearly, that has been a 10% more or less rally and in a very short span of time. So, somewhere or the other stocks are definitely witnessing some profit booking … Read more
Mutual funds reduced holdings in 10 major companies in December, with the highest selling in HDFC Bank (Rs 6,154 crore), followed by Voltas, HCL Tech, Hindustan Aeronautics, and Mphasis, indicating a shift in investment strategies. Source link
Brokerage firms like UBS have a neutral rating on Bharti Airtel, while Nomura has buy ratings on Macrotech Developers and BPCL. Additionally, Nuvama and Jefferies hold buy ratings on Federal Bank and Sun Pharma, respectively. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: UBS on Bharti Airtel: … Read more
After BSE has announced that it will discontinue Bankex weekly expiries, the market is rife with speculations that NSE may choose Nifty Bank over Nifty as both exchanges have to pick one expiry under new Sebi rules. Nifty Bank brings in higher volumes for the exchange, and better trading opportunities for speculators, but if Nifty … Read more
“I think the broader call one will have to take only post getting the clarity on the earnings picture. But my overall view is that the Nifty or the largecap companies by and large should hold out. I do not see a reason for a significant downward correction as far as the Nifty and the … Read more
“Mutual fund figures for I think the last month are still to come out, but they should be healthy. So, there are flows into mutual funds, PMS, AIF, etc. So, I think that keeps the market buoyant. On the other hand, we are also seeing huge supply these days, like on a daily basis now … Read more
“For this September series, we expect the range for September series for Nifty is 24,800 on the downside and on the higher side 25,600, this is going to be the possible range for Nifty. For Bank Nifty, the immediate supply zone which is placed is around 51,500 which is very important level to cross on … Read more